🔴 Absci is trading 5% down today with no clear company-specific catalyst

Absci is trading 5.20% down now at $8.38, with no clear company-specific catalyst identified for the September 2, 2026 decline.

• The latest company announcement, dated September 1, concerned upcoming investor conferences, including a Morgan Stanley healthcare conference on September 16.
• Biotechnology and major U.S. indexes are trading higher, so the decline does not appear aligned with broader sector or market momentum.
• Recent earnings and ABS-201 data were prior catalysts, not new September 2 announcements.